Precision Diagnostics

Specialised in DNA & Molecular Diagnostics 🔬

PRECISE Pharmacogenomics 🧬 First Clinical Recommended Genome-Wide Pharmacogenomics

PRECISE Nutrigenomics 🍎 Only Needed Once in a Lifetime #1

Global Precision Diagnostics Sdn Bhd 202201028139 (1473836-U) Echoing the mission of Beacon Hospital to be A Good Hospital, GPD is committed to providing creditable and cutting-edge diagnostics services to supp

ort good healthcare services at affordable prices. The GPD PRECISE PGx Reporting is curated using the medical database accredited by the Health Science Authority (HSA), Singapore for clinical recommendation and personalized target treatment tailored to clinicians. The AI Algorithm of PRECISE PGx Reporting has attained ISO13485 accreditation by the United Kingdom Accreditation Service (UKAS) for Quality Management System monitored by National Quality Assurance (NQA). We are honoured that GPD's PRECISE PGx has been awarded "First Clinical Recommended Genome-wide Pharmacogenomics", under The Malaysia Book of Records 2023. Dr Rebecca, GPD's CEO having Dual PhDs in Pharmacy (The University of Nottingham, UK) and Molecular Medicine (University of Putra Malaysia), is the principal investigator of the research collaboration agreement with the National University of Singapore (NUS) on the "Implementation of Pharmacogenomics - A Precision Medicine Initiative". GPD teams up with global and nationally renowned pathologists, top scientist recipients, clinicians, pharmacists, genetic counsellors, bioinformaticians, and universities to ensure stringent compliance on MS ISO15189 and CAP compliance, design effective clinical decision support such as interpretation and communication of genomics analysis where the patients can benefit the most.